Journal profile · Pharmacology & Pharmacy
Iranian Journal of Pharmaceutical Research
ISSN 1735-0328 · eISSN 1726-6890 · Iranian Journal of Pharmaceutical Research · IRAN · Quarterly · Founded 2002
Iranian Journal of Pharmaceutical Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.64; fully open access; median 102 days to acceptance (113 articles, last 24 months); community-reported acceptance: about 72.5%; 110 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Iranian Journal of Pharmaceutical Research is published by Iranian Journal of Pharmaceutical Research and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Essential Oils and Antimicrobial Activity, Phytochemistry and Biological Activities and Neuroscience and Neuropharmacology Research, together about 25.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication, scheduled to appear quarterly and serve as a means for scientific information exchange in the international pharmaceutical forum. Specific scientific topics of interest to the journal include, but are not limited to: pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, biotechnology, nanotechnology, biopharmaceutics and physical pharmacy.
Source: LetPub
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences11.2%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences8.6%
- Neuroscience and Neuropharmacology ResearchNeuroscience6%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.2%
- Natural Antidiabetic Agents StudiesMedicine5.2%
- Pain Mechanisms and TreatmentsMedicine4.8%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.8%
- Phytochemicals and Antioxidant ActivitiesMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.64LetPub ·
- CiteScore 2026-06
- 2.9LetPub ·
- SJR 2026-06
- 0.43LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 31LetPub ·
- h-index
- 38OpenAlex ·
- i10-index
- 176OpenAlex ·
- 2-year mean citedness
- 1.36OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 99.57%LetPub ·
Volume
- Articles per year
- 101LetPub ·
Articles by year OpenAlex count · 1,248 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 97 | 97 | 10 |
| 2025 | 110 | 110 | 148 |
| 2024 | 74 | 74 | 223 |
| 2023 | 84 | 84 | 438 |
| 2022 | 78 | 77 | 1,902 |
| 2021 | 2 | 2 | 9 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
102 daysMedian, submission to acceptance · P25–P75 61 days – 155 days
- Acceptance to online
- median 16 days (113 articles)
- Submission to online
- median 136 days
- Sample
- 113 articles with submission and acceptance dates (226 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 72.5%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Iranian Journal of Pharmaceutical Research
- Country or region
- IRAN
- Language
- English
- Frequency
- Quarterly
- Founded
- 2002
- ISSN
- 1735-0328
- Electronic ISSN
- 1726-6890
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Iranian Journal of Pharmaceutical Research
What CAS zone is Iranian Journal of Pharmaceutical Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Iranian Journal of Pharmaceutical Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Iranian Journal of Pharmaceutical Research?
The latest impact factor listed by LetPub is 1.64; CiteScore 2.9, h-index 38.
How long does peer review take at Iranian Journal of Pharmaceutical Research?
Based on the dates recorded on 113 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 61–155 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 72.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Iranian Journal of Pharmaceutical Research?
According to LetPub and DOAJ records, Iranian Journal of Pharmaceutical Research is indexed in SCIE and Scopus.
Is Iranian Journal of Pharmaceutical Research open access, and what is the APC?
Iranian Journal of Pharmaceutical Research is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .